Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription 10.09.2018 2 Am J Epidemiol 1 Arch Bronconeumol 1 BMC Cancer 1 Cancer 2 Cancer Epidemiol Biomarkers Prev 2 Cancer Sci 1 Chest 3 Clin Nucl Med 1 Hum Pathol 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 2 JAMA Oncol 1 Lancet Oncol 1 Mol Cancer Ther 6 N Engl J Med 3 Oncogene 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Epidemiol

1. SILVERMAN DT
   Response to Letter-to-the-Editor Re: "Invited commentary: Diesel exhaust and lung cancer - aftermath of becoming an IARC Group 1 carcinogen" by Ellen T. Chang, Edmund C. Lau, Cynthia Van Landingham, Kenny S. Crump, Roger O. McClellan, Suresh H. Moolga
   Am J Epidemiol. 2018 Sep 6. pii: 5091770. doi: 10.1093.
   PubMed     Text format    
   
   
2. CHANG ET, Lau EC, Van Landingham C, Crump KS, et al
   Response to "Invited commentary: diesel exhaust and lung cancer -- aftermath of becoming an IARC Group 1 carcinogen" by Debra T. Silverman. Am J Epidemiol 2018 Mar 7. doi: 10.1093/aje/kwy036.
   Am J Epidemiol. 2018 Sep 6. pii: 5091771. doi: 10.1093.
   PubMed     Text format    
   
   

   
   Arch Bronconeumol

3. CABRERA CESAR E, Fernandez Aguirre MDC, Reina Marfil N, Velasco Garrido JL, et al
   Diagnosis of Adrenocortical Carcinoma by Flexible Bronchoscopy.
   Arch Bronconeumol. 2018;54:171-172.
   PubMed     Text format    
   
   

   
   BMC Cancer

4. VANHOVE K, Giesen P, Owokotomo OE, Mesotten L, et al
   The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer.
   BMC Cancer. 2018;18:868.
   PubMed     Text format     Abstract available
   
   

   
   Cancer

5. HATA A, Katakami N, Kaji R, Yokoyama T, et al
   Afatinib Plus Bevacizumab Combination After Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Multicenter, Single-Arm, Phase 2 Trial (ABC Study).
   Cancer. 2018 Sep 7. doi: 10.1002/cncr.31678.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Epidemiol Biomarkers Prev

6. GUO Y, Zhang R, Shen S, Wei Y, et al
   DNA Methylation of LRRC3B: A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer Patients.
   Cancer Epidemiol Biomarkers Prev. 2018 Sep 5. pii: 1055-9965.EPI-18-0454.
   PubMed     Text format     Abstract available
   
   
7. ERICKSON P, Gardner LD, Loffredo CA, St George DM, et al
   Racial and Ethnic Differences in the Relationship Between Aspirin Use and Non-Small Cell Lung Cancer Risk and Survival.
   Cancer Epidemiol Biomarkers Prev. 2018 Aug 31. pii: 1055-9965.EPI-18-0366.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Sci

8. GONG WJ, Liu JY, Yin JY, Cui JJ, et al
   Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF-kappaB pathway.
   Cancer Sci. 2018;109:2391-2400.
   PubMed     Text format     Abstract available
   
   
9. ZHU Y, Tang L, Zhao S, Sun B, et al
   CXCR4-mediated osteosarcoma growth and pulmonary metastasis is suppressed by MicroRNA-613.
   Cancer Sci. 2018;109:2412-2422.
   PubMed     Text format     Abstract available
   
   

   
   Chest

10. SURESH K, Naidoo J, Lin CT, Danoff S, et al
    Immune checkpoint immunotherapy for non-small cell lung cancer: benefits and pulmonary toxicities.
    Chest. 2018 Sep 3. pii: S0012-3692(18)32336-5. doi: 10.1016/j.chest.2018.08.1048
    PubMed     Text format     Abstract available
    
    

    
    Clin Nucl Med

11. BACKHAUS P, Huss S, Kosek V, Weckesser M, et al
    Lung Metastases of Intracranial Atypical Meningioma Diagnosed on Posttherapeutic Imaging After 177Lu-DOTATATE Therapy.
    Clin Nucl Med. 2018;43:e184-e185.
    PubMed     Text format     Abstract available
    
    
12. PATEL T, Oldan J
    Imaging of Metastatic Epithelioid Trophoblastic Tumor With 18F-FDG PET/CT.
    Clin Nucl Med. 2018 Apr 13. doi: 10.1097/RLU.0000000000002083.
    PubMed     Text format     Abstract available
    
    
13. ARORA S, Damle NA, Aggarwal S, Passah A, et al
    Prostate-Specific Membrane Antigen Expression in Adrenocortical Carcinoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT.
    Clin Nucl Med. 2018 Mar 24. doi: 10.1097/RLU.0000000000002064.
    PubMed     Text format     Abstract available
    
    

    
    Hum Pathol

14. CHEN X, Shao W, Huang H, Feng X, et al
    Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer.
    Hum Pathol. 2018 Aug 30. pii: S0046-8177(18)30329.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

15. TREUE D, Bockmayr M, Stenzinger A, Heim D, et al
    Proteogenomic systems analysis identifies targeted therapy resistance mechanisms in EGFR-mutated lung cancer.
    Int J Cancer. 2018 Sep 5. doi: 10.1002/ijc.31845.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

16. FERRIS MJ, Jiang R, Behera M, Ramalingam SS, et al
    Radiation Therapy Is Associated With an Increased Incidence of Cardiac Events in Patients with Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2018;102:383-390.
    PubMed     Text format     Abstract available
    
    

    
    JAMA Oncol

17. GRIDELLI C, de Castro Carpeno J, Dingemans AC, Griesinger F, et al
    Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer: The AvaALL Randomized Clinical Trial.
    JAMA Oncol. 2018 Aug 30:e183486. doi: 10.1001/jamaoncol.2018.3486.
    PubMed     Text format     Abstract available
    
    
18. FERRARA R, Mezquita L, Texier M, Lahmar J, et al
    Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy.
    JAMA Oncol. 2018 Sep 6. pii: 2698845. doi: 10.1001/jamaoncol.2018.3676.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Oncol

19. BLACKHALL F, Frese KK, Simpson K, Kilgour E, et al
    Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
    Lancet Oncol. 2018;19:e470-e481.
    PubMed     Text format     Abstract available
    
    

    
    Mol Cancer Ther

20. MOCHIZUKI S, Shimoda M, Abe H, Miyamae Y, et al
    Selective inhibition of ADAM28 suppresses lung carcinoma cell growth and metastasis.
    Mol Cancer Ther. 2018 Sep 6. pii: 1535-7163.MCT-17-1198.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

21. AL-KINDI S, Al-Juhaishi T, Yaqoob Z
    Incidence of Lung Cancer among Young Women.
    N Engl J Med. 2018;379:988-9.
    PubMed     Text format    
    
    
22. BERLIN I
    Incidence of Lung Cancer among Young Women.
    N Engl J Med. 2018;379:988.
    PubMed     Text format    
    
    
23. FUNATOGAWA I
    Incidence of Lung Cancer among Young Women.
    N Engl J Med. 2018;379:988.
    PubMed     Text format    
    
    
24. 
    Incidence of Lung Cancer among Young Women.
    N Engl J Med. 2018;379:988-991.
    PubMed     Text format    
    
    
25. LOMMATZSCH M, Bratke K, Stoll P
    Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
    N Engl J Med. 2018;379:e14.
    PubMed     Text format    
    
    
26. YANG X, Yin R, Xu L
    Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
    N Engl J Med. 2018;379:e14.
    PubMed     Text format    
    
    

    
    Oncogene

27. LIN YP, Wu JI, Tseng CW, Chen HJ, et al
    Gjb4 serves as a novel biomarker for lung cancer and promotes metastasis and chemoresistance via Src activation.
    Oncogene. 2018 Sep 3. pii: 10.1038/s41388-018-0471.
    PubMed     Text format     Abstract available
    
    
28. LIANG SQ, Buhrer ED, Berezowska S, Marti TM, et al
    mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer.
    Oncogene. 2018 Aug 31. pii: 10.1038/s41388-018-0479.
    PubMed     Text format     Abstract available
    
    
29. YOCHUM ZA, Cades J, Wang H, Chatterjee S, et al
    Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer.
    Oncogene. 2018 Aug 31. pii: 10.1038/s41388-018-0482.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

30. WENG MW, Lee HW, Park SH, Hu Y, et al
    Aldehydes are the predominant forces inducing DNA damage and inhibiting DNA repair in tobacco smoke carcinogenesis.
    Proc Natl Acad Sci U S A. 2018;115:E6152-E6161.
    PubMed     Text format     Abstract available
    
    
31. FAN PD, Narzisi G, Jayaprakash AD, Venturini E, et al
    YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics.
    Proc Natl Acad Sci U S A. 2018;115:E6030-E6038.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: